Mark Hallen
Signal active
Co-founder and CTO
Contact Information
Social
Primary Organization
Ten63 Therapeutics
Founded
2017
Employees
11-50
Industry
Biotechnology, Health Care, Pharmaceutical, Medical
Bio
Mark Hallen serves as a co-founder and CTO at Ten63 Therapeutics. He attended Duke University.
Location
San Mateo De Bages, Catalonia, Spain, Europe
Jobs history
1
Ten63 Therapeutics
Co-founder and CTO
2018 - Current
Educations
1
Duke University
Computer science
Profile Resume
Mark Hallen is the Co-founder and CTO at Ten63 Therapeutics, based in Europe. With a background in Biotechnology, Mark Hallen has a rich history of leadership and innovation.Mark Hallen studied phD Computer science at Duke University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.